Berman Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $89K | Buy |
1,880
+170
| +10% | +$8.05K | 0.01% | 476 |
|
|
2021
Q2 | $71K | Buy |
1,710
+66
| +4% | +$2.74K | 0.01% | 465 |
|
|
2021
Q1 | $54K | Buy |
1,644
+160
| +11% | +$5.26K | 0.01% | 453 |
|
|
2020
Q4 | $51K | Hold |
1,484
| – | – | 0.01% | 404 |
|
|
2020
Q3 | $50K | Sell |
1,484
-112
| -7% | -$3.77K | 0.01% | 341 |
|
|
2020
Q2 | $51K | Buy |
1,596
+852
| +115% | +$27.2K | 0.01% | 321 |
|
|
2020
Q1 | $22K | Buy |
744
+216
| +41% | +$6.39K | 0.01% | 472 |
|
|
2019
Q4 | $15K | Buy |
528
+12
| +2% | +$341 | ﹤0.01% | 618 |
|
|
2019
Q3 | $13K | Buy |
516
+2
| +0.4% | +$50 | ﹤0.01% | 641 |
|
|
2019
Q2 | $13K | Buy |
514
+148
| +40% | +$3.74K | ﹤0.01% | 646 |
|
|
2019
Q1 | $9K | Sell |
366
-1,822
| -83% | -$44.8K | ﹤0.01% | 698 |
|
|
2018
Q4 | $49K | Buy |
+2,188
| New | +$49K | 0.02% | 254 |
|